The table below shows AGIOS PHARMACEUTICALS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q2 2026
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Revenue
$44.74M
$20.75M
$12.88M
$12.46M
$8.73M
$8.96M
Cost of revenue
$3.00M
$1.32M
$1.68M
$1.70M
$1.08M
$783.00K
Gross profit
-
-
-
-
-
-
R&D
$100.75M
$81.15M
$86.80M
$91.94M
$72.74M
$72.45M
AGIO annual revenue (10-K history)
AGIOS PHARMACEUTICALS, INC. reported annual revenue of $54.03M for fiscal year 2025. That is up 48.0% from $36.50M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $69.89M (FY 2016) to $54.03M. Figures come from the company's audited annual reports as filed with the SEC.
